References
- Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME. 2009. Probiotics and immunity. J Gastroenterol 44:26–46
- Chen Z, Thompson SK, Jamieson GG, Devitt PG, Watson DI. 2011. Effect of sex on symptoms associated with gastroesophageal reflux. Arch Surg 146:1164–1169
- Corthesy B. 2013. Role of secretory IgA in infection and maintenance of homeostasis. Autoimmunity Rev 12:661–665
- Corthesy B, Gaskins HR, Mercenier A. 2007. Cross-talk between probiotic bacteria and the host immune system. J Nutr 137:781S–790S
- Czinn SJ, Blanchard S. 2013. Gastroesophageal reflux disease in neonates and infants: when and how to treat. Paediatr Drugs 15:19–27
- Ericson D, Hamberg K, Bratthall G, Sinkiewicz-Enggren G, Ljunggren L. 2013. Salivary IgA response to probiotic bacteria and mutans streptococci after the use of chewing gum containing Lactobacillus reuteri. Pathog Dis 68:82–87
- Forsberg A, Abrahamsson R, Jenmalm MC, Björkstén RB. 2013. Pre- and post-natal Lactobacillus reuteri supplementation decreases allergen responsiveness in infancy. Clin Exp Allergy 43:434–442
- Indrio F, Riezzo G, Raimondi F, Bisceglia M, Filannino A, Cavallo L, Francavilla R. 2011. Lactobacillus reuteri accelerates gastric emptying and improves regurgitation in infants. Eur J Clin Invest 41:417–422
- Kawano A, Emori Y. 2013. Changes in maternal secretory immunoglobulin a levels in human milk during 12 weeks after parturition. Am J Hum Biol 25:399–403
- Keefe MR, Lobo ML, Froese-Fretz A, Kotzer AM, Barbosa GA, Dudley WN. 2006. Effectiveness of an intervention for colic. Clin Pediatr 45:123–133
- Kunze WA, Mao YK, Wang B, Huizinga JD, Ma X, Forsythe P, Bienenstock J. 2009. Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium dependent potassium channel opening. J Cell Mol Med 13:2261–2270
- Mellander L, Carlsson B, Hanson LA. 1984. Appearance of secretory IgM and IgA antibodies to Escherichia coli in saliva during early infancy and childhood. J Pediatr 104:564–568
- Mihatsch WA, Braegger CP, Decsi T, Kolacek S, Lanzinger H, Mayer B, Moreno LA, et al. 2012. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clin Nutr 31:6–15
- Rautava S. 2007. Potential uses of probiotics in the neonate. Semin Fetal Neonatal Med. 12:45–53
- Rojas MA, Lozano JM, Rojas MX, Rodriguez VA, Rondon MA, Bastidas JA, Perez LA, et al. 2012. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 130:e1113–1120
- Savino F, Cordisco L, Tarasco V, Palumeri E, Calabrese R, Oggero R, Roos S, Matteuzzi D. 2010. Lactobacillus reuteri DSM 17938 in infantile colic: a randomized, double-blind, placebo-controlled trial. Pediatrics 126:e526–e533
- Sjögren YM, Tomicic S, Lundberg A, Böttcher MF, Björkstén B, Sverremark-Ekström E, Jenmalm MC. 2009. Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin Exp Allergy 12:1842–1851
- Wang B, Mao YK, Diorio C, Wang L, Huizinga JD, Bienenstock J, Kunze W. 2010. Lactobacillus reuteri ingestion and IK(Ca) channel blockade have similar effects on rat colon motility and myenteric neurones. Neurogastroenterol Motil 22:98–107, e33